Costanzo A, Russo F, Galluzzo M, Stingeni L, Scuderi R, Zichichi L, et al. Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study. Acta Derm Venereol [Internet]. 2021 Oct. 21 [cited 2024 Aug. 5];101(10):adv00576. Available from: https://medicaljournalssweden.se/actadv/article/view/468